PER
Click for more information
1.27% 8.0¢ percheron therapeutics limited

terms of agreement, page-24

  1. skyrocketer
    1,496 Posts.
    clock Created with Sketch.
    18/07/12
    15:48
    Post #: 10451000
    Abdm

    It is a surprised for a well research poster such as yourself to think that ANP is giving away the patents/licenses of ATL1102 for free.

    Obviously placed no value in the cost needed for clinical trials, which is the main activity/concern as a Biotech before the exit point to a big Pharma in Phase III.




    ANP Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate
right-arrow Created with Sketch.
NEWS RBA holds rates as ALP election campaigning kicks off – expect more political focus
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.001(1.27%) 		Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.